Orchid Pharma Ltd - 524372 - Un-Audited Financial Results For The Quarter Ended June 30Th 2022
Un-Audited Financial Results for the Quarter ended June 30th 202210-08-2022
10-08-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investors Presentation on Un-Audited Standalone & Consolidated Financial Results for the Quarter Ended 30 June, 202210-08-2022
Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 10, 2022
We refer to our communication dated August 01, 2022 submitted to your good office pertaining to the Board Meeting to be held on August 10, 2022. Further, in accordance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, we would like to inform that the Board of Directors at their Meeting held today i.e., August 10, 2022 have inter-alia considered, approved and taken on record the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended June 30, 2022 (Q1 of Financial year 2022-23) along with the Limited Review Report (s) of the Statutory Auditors on the same. A copy of the Unaudited Financial Results (Standalone and consolidated) along with the Limited Review Report (s) issued by the Statutory Auditors is enclosed.10-08-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We would like to inform you that an Investor Conference Call is scheduled to be held on Wednesday, August 10, 2022 at 4:00 P.M. (Indian Standard Time) to discuss the financial performance of the Company for the quarter ended June 30, 2022 (Q1 of Financial Year 2022-2023).05-08-2022
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Meeting Of Board Of Directors - 10Th August, 2022(Wednesday)
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve Un-Audited Standalone & Consolidated Financial Results of the Company for the Quarter ended 30th June, 2022.01-08-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Dear Sir/ Madam, With reference to the captioned subject and in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby inform you that Ms Nikita K has tendered her resignation from the post of Company Secretary & Compliance Officer of the Company w.e.f 22nd July 2022 (after the closing business hours) due to her personal reasons. The Resignation Letter shall be placed before the Board of Directors in the upcoming Board Meeting for their consideration and formal acceptance in accordance with the aforementioned regulation. Request you to take the same on your records. Thanking you22-07-2022
Orchid Pharma Ltd - 524372 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Nikita KDesignation :- Company Secretary and Compliance Officer20-07-2022
Orchid Pharma Ltd - 524372 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Orchid Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here18-07-2022
Orchid Pharma Ltd - 524372 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Outcome of 29th AGM and Scrutinizer''s report17-07-2022
Orchid Pharma Ltd - 524372 - Proceedings Of The 29Th Annual General Meeting
Proceedings of the 29th Annual General meeting16-07-2022